Initiation and characterization of small cell lung cancer patient-derived xenografts from ultrasound-guided transbronchial needle aspirates

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Anderson, Wade C ^b   Boyd, Michael B ^a   Aguilar, Jorge ^b   Pickell, Brett ^b   Laysang, Amy ^b   Pysz, Marybeth A ^b   Bheddah, Sheila ^b   Ramoth, Johanna ^b   Slingerland, Brian C ^b   Dylla, Scott J ^b   Rubio, Edmundo R ^a  

^a VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^b Stemcentrx   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN A; CISPLATIN; CYTOKERATIN 14; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; EPITHELIAL CELL ADHESION MOLECULE; ETOPOSIDE; NAPSIN A; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; TP63; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER MORPHOLOGY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; DRUG RESPONSE; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OVERALL SURVIVAL; PRIMARY TUMOR; SMALL CELL LUNG CANCER; TRANSBRONCHIAL ASPIRATION; TUMOR MODEL; TUMOR XENOGRAFT; ANIMAL; BRONCHUS; DIAGNOSTIC IMAGING; DRUG SCREENING; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; IMMUNOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; BRONCHI; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MIDDLE AGED; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME; ULTRASONOGRAPHY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84940427235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125255     Document Type: Article

References (29)

1. Tarver T. Cancer Facts & Figures 2012. American Cancer Society (ACS). Journal of Consumer Health on the Internet. 2012; 16:366-7.
2. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. Small cell lung cancer: have we made any progress over the last 25 years? Oncologist. 2007; 12:1096-104. PMID: 17914079
3. Park SH, Cho EK, Kim Y, Kyung SY, An CH, Lee SP, et al. Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer. Cancer chemotherapy and pharmacology. 2008; 62:1009-14. doi: 10.1007/s00280-008-0690-1 PMID: 18259751
4. Owonikoko TK, Behera M, Chen Z, Bhimani C, Curran WJ, Khuri FR, et al. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2012; 7:866-72.
5. O'Brien ME, Ciuleanu TE, Tsekov H, Shparyk Y, Cucevia B, Juhasz G, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006; 24:5441-7.
6. Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012; 9:338-50. doi: 10.1038/nrclinonc.2012.61 PMID: 22508028
7. Jin K, Teng L, Shen Y, He K, Xu Z, Li G. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clin Transl Oncol. 2010; 12:473-80. doi: 10.1007/s12094-010-0540-6 PMID: 20615824
8. Williams SA, Anderson WC, Santaguida MT, Dylla SD. Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Laboratory investigation; a journal of technical methods and pathology. 2013; 93:970-82. doi: 10.1038/labinvest.2013.92 PMID: 23917877
9. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, et al. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer research. 2003; 63:8634-47. PMID: 14695175
10. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer research. 2009; 69:3364-73. doi: 10.1158/0008-5472.CAN-08-4210 PMID: 19351829
11. Leong TL, Marini KD, Rossello FJ, Jayasekara SN, Russell PA, Prodanovic Z, et al. Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens. PLoS ONE. 2014; 9(9): e106862. doi: 10.1371/journal.pone.0106862 PMID: 25191746
12. Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, et al. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J Natl Cancer Inst. 1993; 85:2023-9. PMID: 7902445
13. Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F, et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med. 2014; 8:897-903.10. doi: 10. 1038/nm.3600 PMID: 24880617
14. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2004; 22:3248-54.
15. Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2007; 2:1067-77.
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American journal of clinical oncology. 1982; 5:649-55. PMID: 7165009
17. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006; 61:795-8. PMID: 16738038
18. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute. 2000; 92:205-16. PMID: 10655437
19. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104:10158-63. PMID: 17548814
20. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE. 2008; 3:e2428. doi: 10.1371/journal. pone.0002428 PMID: 18560594
21. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. The European respiratory journal. 2001; 18:1059-68. PMID: 11829087
22. Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research. 2010; 16:1442-51. doi: 10.1158/1078-0432.CCR-09-2878 PMID: 20179238
23. Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, et al. A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clinical cancer research: an official journal of the American Association for Cancer Research. 2007; 13:3989-98. PMID: 17606733
24. Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, et al. Molecular profiling of patientderived breast cancer xenografts. Breast Cancer Res. 2012; 14:R11. PMID: 22247967
25. Pandita A, Aldape KD, Zadeh G, Guha A, James CD. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer. 2004; 39:29-36. PMID: 14603439
26. De Witt Hamer PC, Van Tilborg AA, Eijk PP, Sminia P, Troost D, Van Noorden CJ, et al. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene. 2008; 27:2091-6. PMID: 17934519
27. Sasai K, Romer JT, Lee Y, Rinkelstein D, Fuller C, McKinnon PJ, et al. Shh pathway activity is downregulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer research. 2006; 66:4215-22. PMID: 16618744
28. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature. 1983; 306:194-6. PMID: 6646201
29. Grigorova M, Lyman RC, Caldas C, Edwards PA. Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping. Cancer genetics and cytogenetics. 2005; 162:1-9. PMID: 16157194